Standardization of the one-stage assay for factor VIII (antihemophilic factor)

American Journal of Clinical Pathology
L R Zacharski, R Rosenstein

Abstract

Although considerable progress has been made in perfecting the one-stage assay for factor VIII (antihemophilic factor), there remain variables that influence test results within laboratories as well as reproducibility between laboratories which have not been adequately evaluated. The purpose of this paper is to elucidate certain aspects of this assay that have not received adequate consideration and to describe the authors' assay method in order to provide a basis for comparison with results from other laboratories. It appears that variability results from: (1) differences in coagulability of different batches of substrate plasma obtained at different times from the same individual; (2) instability of some batches of stored substrate or standard plasmas; (3) variation in coagulability among vials of stored substrate or standard plasma from the same batch; (4) variation due to non-plasma reagents and instrumentation used to execute the test.

Citations

Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·S Rosén
Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·J M LusherC R Hillman
Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·J Over
Jan 1, 1984·Scandinavian Journal of Haematology. Supplementum·J Over
Aug 1, 1994·European Journal of Haematology·G OztürkT Gürsel
Mar 14, 2009·The Tohoku Journal of Experimental Medicine·Francisca SantizoRuth Martínez-Cruz
Jul 15, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Peter KubiszDusan Mesko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.